Detalhe da pesquisa
1.
The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.
Int J Cancer
; 148(11): 2799-2806, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33428771